Oxford Nanopore Technologies (LON:ONT) Issues Quarterly Earnings Results

Oxford Nanopore Technologies (LON:ONT) issued its earnings results on Wednesday. The company reported GBX (4.90) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Oxford Nanopore Technologies had a negative net margin of 64.85% and a negative return on equity of 29.43%.

Oxford Nanopore Technologies Stock Up 9.6%

Shares of ONT opened at GBX 133.90 on Wednesday. The company has a market cap of £1.31 billion, a PE ratio of -8.87 and a beta of 0.91. The business has a fifty day moving average of GBX 118.16 and a 200 day moving average of GBX 122.69. Oxford Nanopore Technologies has a 52-week low of GBX 95.61 and a 52-week high of GBX 215.60. The company has a quick ratio of 6.01, a current ratio of 3.56 and a debt-to-equity ratio of 8.96.

Wall Street Analysts Forecast Growth

ONT has been the subject of a number of research analyst reports. Royal Bank Of Canada reaffirmed an “outperform” rating and set a GBX 225 price objective on shares of Oxford Nanopore Technologies in a report on Tuesday, May 26th. Peel Hunt restated a “hold” rating and set a GBX 153 target price on shares of Oxford Nanopore Technologies in a research report on Monday, July 13th. Citigroup lowered shares of Oxford Nanopore Technologies to a “buy” rating in a research report on Monday, July 20th. Finally, Berenberg Bank cut their target price on shares of Oxford Nanopore Technologies from GBX 220 to GBX 200 and set a “buy” rating for the company in a research note on Wednesday. Four research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of GBX 200.75.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.